Bharat Biotech
Search results
Latest News. Indian Immunologicals unveils indigenously developed Hepatitis A vaccine. 19 January 2024. Indian Immunologicals launches measles and rubella vaccine for children. 25November 2023.
IIL is the third largest animal health player in the Indian market and the market leader in veterinary biologicals in India. IIL operates one plant that is WHO-GMP and ISO-9001, 14001, 18001 and 27001 certified.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for veterinary vaccines.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for...
The Animal Health Division of IIL offers a variety of Therapeutic products for Livestock and Companion animals to enhance their productive and reproductive status along with prophylaxis against certain diseases. The product portfolio comprises Vaccines, Formulations and Nutraceuticals.
Oct 8, 1999 · Indian Immunologicals Limited is a Non-govt company, incorporated on 08 Oct, 1999. It's a public unlisted company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1500.0 lakhs and has 60.00005% paid-up capital which is Rs 900.0 lakhs.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for veterinary vaccines.
